By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today reported that its total revenues for full-year 2010 were flat with 2009 at €2.5 million ($3.4 million), as the firm sharply cut its net loss.

The Liege, Belgium-based molecular diagnostics firm reported revenues of nearly €2 million from products and services, up from around €1 million in 2009. Its grant revenues declined to €568,000 from €1.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.